A New Method to Find Cancer Drug Inhibitors
Author Information
Author(s): Rosado Aranzazú, Zanella Fabian, Garcia Beatriz, Carnero Amancio, Link Wolfgang
Primary Institution: Centro Nacional de Investigaciones Oncologicas (CNIO), Madrid, Spain
Hypothesis
Can a new live-cell screening platform identify selective inhibitors of Akt signaling?
Conclusion
The BaFiso platform successfully identifies selective inhibitors of Akt signaling in cancer cells.
Supporting Evidence
- The BaFiso system allows for the identification of specific inhibitors of the Akt pathway.
- The study demonstrated that the platform can distinguish between cancer cells with activated Akt signaling and control cells.
- The use of dual fluorescence enables real-time monitoring of cell viability.
Takeaway
Researchers created a new way to find drugs that can stop cancer cells from growing by using special cells that change color when they are healthy or dying.
Methodology
The study developed a live-cell screening platform called BaFiso using isogenic cell lines tagged with different fluorescent proteins to identify inhibitors of Akt signaling.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website